Olympiad Research’s Pfizer PFE Stock Holding History

Olympiad Research’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,553	Closed	-$267K	–	264
2025 Q1	$267K	Buy	+10,553	New	+$276K	0.31%	106
2022 Q3	$766K	Hold	17,513	–	–	0.41%	70
2022 Q2	$918K	Buy	17,513 +1,217	+7%	+$62K	0.41%	77
2022 Q1	$844K	Hold	16,296	–	–	0.26%	102
2021 Q4	$962K	Buy	16,296 +5,432	+50%	+$269K	0.35%	85
2021 Q3	$467K	Hold	10,864	–	–	0.14%	146
2021 Q2	$425K	Hold	10,864	–	–	0.15%	140
2021 Q1	$394K	Hold	10,864	–	–	0.17%	125
2020 Q4	$400K	Buy	+10,864	New	+$398K	0.23%	77

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Olympiad Research's PFE Position: Q2 2025 in Review

Olympiad Research sold out of Pfizer (PFE) in Q2 2025, closing a stake of 10,553 shares — an estimated $267K sold.

Olympiad Research first reported a position in PFE in Q4 2020 and held it in 9 quarters. The position peaked at $962K in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Olympiad Research reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Olympiad Research sold 10,553 Pfizer shares in Q2 2025, an estimated $267K.
Olympiad Research first reported a position in Pfizer in Q4 2020 and held it in 9 quarters.
Olympiad Research's Pfizer position peaked at $962K in Q4 2021.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Olympiad Research's 13F filing for Q2 2025, filed 8 Aug 2025.